Filing Details

Accession Number:
0001437749-20-020453
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-29 18:28:56
Reporting Period:
2020-09-29
Accepted Time:
2020-09-29 18:28:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
832489 Geovax Labs Inc. GOVX Pharmaceutical Preparations (2834) 870455038
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193607 A David Dodd 1900 Lake Park Drive
Suite 380
Smyrna GA 30080
President, Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-29 81,870 $5.00 81,870 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Purchase Warrant Acquisiton 2020-09-29 81,870 $0.00 81,870 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
81,870 2020-09-29 2025-09-29 No 4 P Direct
Footnotes
  1. These securities are subject to a lock-up agreement, dated August 31, 2020, between the Reporting Person and Maxim Group LLC. The securities may not be sold, exercised, or otherwise transferred prior to March 29, 2021, unless the restrictions are earlier waived by Maxim Group LLC or pursuant to specific exemptions in the lock-up agreement.